A continuing decline in sales of COVID-19 products clips revenue at Pfizer
Pfizer lost more than $2 billion in the third quarter as an expected COVID-19 product sales decline clipped revenue. Sales of the drugmaker's COVID treatment Paxlovid and the vacci…
